Merck hosts first “Bilharzia Storytelling Lab” to support elimination efforts in Kenya
Kenya is one of the recipient countries since 2011 and has been provided with 19.7 million praziquantel tablets to date. Merck is working towards the elimination of this insidious disease, through a comprehensive approach, together with its international partners.

